相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld et al.
CANCER CELL (2020)
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Chiara Porta et al.
CANCER RESEARCH (2020)
Eicosanoids in Cancer: Prostaglandin E2Receptor 4 in Cancer Therapeutics and Immunotherapy
Mc Millan Ching et al.
FRONTIERS IN PHARMACOLOGY (2020)
PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model
Tong Wang et al.
ONCOGENE (2020)
Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors
Eric A. Evangelista et al.
FRONTIERS IN PHARMACOLOGY (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes
Deborah B. Doroshow et al.
CLINICAL CANCER RESEARCH (2019)
Neoantigen-directed immune escape in lung cancer evolution
Rachel Rosenthal et al.
NATURE (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Fatty acid transport protein 2 reprograms neutrophils in cancer
Filippo Veglia et al.
NATURE (2019)
Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
Nune Markosyan et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
EP3 receptor antagonist L798, 106 reduces proliferation and migration of SK-BR-3 breast cancer cells
Anna Hester et al.
ONCOTARGETS AND THERAPY (2019)
Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma
Hui Yang et al.
PHARMACOLOGY (2019)
Regulation of TIM-3 expression in a human T cell line by tumor-conditioned media and cyclic AMP-dependent signaling
Su Jin Yun et al.
MOLECULAR IMMUNOLOGY (2019)
What, Why, Where, and When: Bringing Timing to Immuno-Oncology
Adrienne M. Rothschilds et al.
TRENDS IN IMMUNOLOGY (2019)
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC
Bonnie L. Bullock et al.
LIFE SCIENCE ALLIANCE (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages
Julia Ringleb et al.
JOURNAL OF IMMUNOLOGY (2018)
A RIPK3-PGE(2) Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis
Guifang Yan et al.
CANCER RESEARCH (2018)
The Cytochrome P450 Slow Metabolizers CYP2C9*2 and CYP2C9*3 Directly Regulate Tumorigenesis via Reduced Epoxyeicosatrienoic Acid Production
Lindsay N. Sausville et al.
CANCER RESEARCH (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
5-Lipoxygenase: Its involvement in gastrointestinal malignancies
Neha Merchant et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
Mousumi Majumder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Role of prostanoids in gastrointestinal cancer
Dingzhi Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Leukotriene receptors as potential therapeutic targets
Takehiko Yokomizo et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Targeted overexpression of prostacyclin synthase inhibits lung tumor progression by recruiting CD4+T lymphocytes in tumors that express MHC class II
Howard Y. Li et al.
ONCOIMMUNOLOGY (2018)
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
Douglas B. Johnson et al.
JCI INSIGHT (2018)
Comprehensive analysis of the clinical immuno-oncology landscape
J. Tang et al.
ANNALS OF ONCOLOGY (2018)
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
Xiaohong Wang et al.
CANCER RESEARCH (2017)
Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway
Gillian Y. Moore et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
Victor Prima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Prostaglandin synthases: Molecular characterization and involvement in prostaglandin biosynthesis
Min-Ju Seo et al.
PROGRESS IN LIPID RESEARCH (2017)
The yin and yang of leukotriene B4 mediated inflammation in cancer
Venkatakrishna R. Jala et al.
SEMINARS IN IMMUNOLOGY (2017)
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Sara Trabanelli et al.
NATURE COMMUNICATIONS (2017)
Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets
Sabine Galland et al.
CELL REPORTS (2017)
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
Javier Rodriguez-Ubreva et al.
CELL REPORTS (2017)
Leukotriene B4-receptor-1 mediated host response shapes gut microbiota and controls colon tumor progression
Venkatakrishna R. Jala et al.
ONCOIMMUNOLOGY (2017)
Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer
Saly Al-Taei et al.
ONCOIMMUNOLOGY (2017)
Immune-regulation and -functions of eicosanoid lipid mediators
Julia Esser-von Bieren
BIOLOGICAL CHEMISTRY (2017)
Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment
Joanna M. Poczobutt et al.
JOURNAL OF IMMUNOLOGY (2016)
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors
Zinal S. Chheda et al.
JOURNAL OF IMMUNOLOGY (2016)
Expression Profiling of Macrophages Reveals Multiple Populations with Distinct Biological Roles in an Immunocompetent Orthotopic Model of Lung Cancer
Joanna M. Poczobutt et al.
JOURNAL OF IMMUNOLOGY (2016)
Prostaglandin D2 is a novel repressor of IFNγ induced indoleamine-2,3-dioxygenase via the DP1 receptor and cAMP pathway
Nesrine Kamal Bassal et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2016)
Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
Lorraine Burke et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Stefanie K. Wculek et al.
NATURE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth
Shuchismita R. Satpathy et al.
NATURE COMMUNICATIONS (2015)
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
Z. Wen et al.
ONCOGENE (2015)
Eicosanoid storm in infection and inflammation
Edward A. Dennis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non-Small-Cell Lung Cancer
Pasi A. Jaenne et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E4 Ligand
Yoshihide Kanaoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator-Activated Receptor α
Katarzyna Wejksza et al.
JOURNAL OF IMMUNOLOGY (2013)
Expression of Leukotriene B4 Receptor-1 on CD8+ T Cells Is Required for Their Migration into Tumors To Elicit Effective Antitumor Immunity
Rajesh Kumar Sharma et al.
JOURNAL OF IMMUNOLOGY (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment
Joanna M. Poczobutt et al.
PLOS ONE (2013)
Proinflammatory anc immunoregulatory roles of eicosanoids in T cells
Anna Mari Lone et al.
FRONTIERS IN IMMUNOLOGY (2013)
Lipids and eicosanoids in fibrosis: emerging targets for therapy
Flavia V. Castelino
CURRENT OPINION IN RHEUMATOLOGY (2012)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cyclooxygenases and lipoxygenases in cancer
Claus Schneider et al.
CANCER AND METASTASIS REVIEWS (2011)
Prostaglandin catabolic enzymes as tumor suppressors
Hsin-Hsiung Tai
CANCER AND METASTASIS REVIEWS (2011)
Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention
Mary-Clare Cathcart et al.
CANCER AND METASTASIS REVIEWS (2011)
Chemoprevention of Colon and Small Intestinal Tumorigenesis in APCMin/+ Mice by Licofelone, a Novel Dual 5-LOX/COX Inhibitor: Potential Implications for Human Colon Cancer Prevention
Altaf Mohammed et al.
CANCER PREVENTION RESEARCH (2011)
Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers
Robert L. Keith et al.
CANCER PREVENTION RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Regulation of inflammation in cancer by eicosanoids
Emily R. Greene et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2010)
5-Lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis
Dieter Steinhilber et al.
FRONTIERS IN PHARMACOLOGY (2010)
New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development
Juan J. Moreno
BIOCHEMICAL PHARMACOLOGY (2009)
Targeting the eicosanoid pathway in non-small-cell lung cancer
Leora Horn et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non-Small Cell Lung Cancer
Duncan Hughes et al.
CANCER PREVENTION RESEARCH (2008)
Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib plus chemotherapy - Cancer and leukemia group B trial 30203
Martin J. Edelman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Peroxisome proliferator-activated receptor γ and lung cancer biology
Jesse Roman
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase
Daniel DiMeo et al.
IMMUNOLOGY (2008)
Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities
David M. Aronoff et al.
JOURNAL OF IMMUNOLOGY (2007)
Inflammation and breast cancer: Hypothesis for targeted therapies
A. Mantovani
BREAST (2007)
Cyclooxygenases and lipoxygenases in prostate and breast cancers
Daotai Nie
FRONTIERS IN BIOSCIENCE (2007)
Targeting tumour-associated macrophages
Antonio Sica et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Roles of cPLA2α and arachidonic acid in cancer
Masako Nakanishi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cysteinyl-leukotriene receptor antagonists: Present situation and future opportunities
V. Capra et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Lipoxygenase pathway of arachidonic acid metabolism in growth control of tumor cells of different type
IA Kudryavtsev et al.
BIOCHEMISTRY-MOSCOW (2005)
LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways
WG Tong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: A phase II trial of celecoxib and docetaxel
I Csiki et al.
CLINICAL CANCER RESEARCH (2005)
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells
F Baratelli et al.
JOURNAL OF IMMUNOLOGY (2005)
PPARγ as a therapeutic target for tumor angiogenesis and metastasis
D Panigrahy et al.
CANCER BIOLOGY & THERAPY (2005)
LTB4 is present in exudative pleural effusions and contributes actively to neutrophil recruitment in the inflamed pleural space
E Pace et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice
RL Keith et al.
CANCER RESEARCH (2004)
Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists
C Grommes et al.
LANCET ONCOLOGY (2004)
Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment
AM Tager et al.
NATURE IMMUNOLOGY (2003)
Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues
K Goodarzi et al.
NATURE IMMUNOLOGY (2003)
Evaluation of eicosanoids and NSAIDs as PPARγ ligands in colorectal carcinoma cells
JB Nixon et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice
LR Kisley et al.
CARCINOGENESIS (2002)
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
MT Yip-Schneider et al.
CARCINOGENESIS (2000)
分享论文
